[CLDX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -25.43%
YoY- -42.85%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,191 1,517 407 153 668 546 941 22.54%
PBT -42,121 -38,260 -26,784 -20,679 -14,224 -11,413 -7,243 34.06%
Tax 0 -2,979 -912 -227 1,088 -5,090 -14,912 -
NP -42,121 -38,260 -26,784 -20,452 -14,224 -11,413 -7,243 34.06%
Tax Rate - - - - - - - -
Total Cost 45,312 39,777 27,191 20,605 14,892 11,959 8,184 32.97%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -1,319.99 -2,522.08 -6,580.84 -13,367.32 -2,129.34 -2,090.29 -769.71 9.39%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.64 -0.81 -0.57 -0.45 -0.36 -0.75 -0.66 -0.51%
EPS Diluted -0.64 -0.81 -0.57 -0.45 -0.36 -0.75 -0.66 -0.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.